1. Decker, Brennan, Allen, Jamie, Luccarini, Craig, Dunning, Alison M, Easton, Douglas F. 2017. Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks. In Journal of medical genetics, 54, 732-741. doi:10.1136/jmedgenet-2017-104588. https://pubmed.ncbi.nlm.nih.gov/28779002/
2. Talar-Wojnarowska, Renata, Gąsiorowska, Anita, Olakowski, Marek, Smolarz, Beata, Małecka-Panas, Ewa. 2015. Analysis of XRCC2 and XRCC3 gene polymorphisms in pancreatic cancer. In Biomedical reports, 4, 236-240. doi:. https://pubmed.ncbi.nlm.nih.gov/26893845/
3. França, Monica Malheiros, Mendonca, Berenice Bilharinho. 2021. Genetics of ovarian insufficiency and defects of folliculogenesis. In Best practice & research. Clinical endocrinology & metabolism, 36, 101594. doi:10.1016/j.beem.2021.101594. https://pubmed.ncbi.nlm.nih.gov/34794894/
4. Gowtham Kumar, G, Paul, Solomon Franklin Durairaj, Martin, Jovita, Usha Rani, G, Andrea Mary, Francis. 2021. Association between RAD51, XRCC2 and XRCC3 gene polymorphisms and risk of ovarian cancer: a case control and an in silico study. In Molecular biology reports, 48, 4209-4220. doi:10.1007/s11033-021-06434-6. https://pubmed.ncbi.nlm.nih.gov/34097201/
5. Kaur, Jagjeet, Sambyal, Vasudha, Guleria, Kamlesh, Manjari, Mridu, Sudan, Meena. 2020. Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk. In Clinical and experimental gastroenterology, 13, 73-86. doi:10.2147/CEG.S232961. https://pubmed.ncbi.nlm.nih.gov/32214837/
6. Li, Xia-Bin, Luo, Hua, Huang, Juan, Yang, Zi-Xi, Sun, Xing-Wang. 2014. XRCC2 gene polymorphisms and its protein are associated with colorectal cancer susceptibility in Chinese Han population. In Medical oncology (Northwood, London, England), 31, 245. doi:10.1007/s12032-014-0245-8. https://pubmed.ncbi.nlm.nih.gov/25304007/